Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1994-04-07
1996-05-07
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514182, 514899, 514938, 552607, 552625, 424434, 424450, A61K 9113, A61K 3156
Patent
active
055146732
ABSTRACT:
A pharmaceutical composition having a form suitable for transmucosal administration containing progesterone and/or 17-.beta.-estradiol as an active ingredient.
REFERENCES:
patent: 4053489 (1977-10-01), Wirth
patent: 4078060 (1978-03-01), Benson
patent: 4096254 (1978-06-01), Benson
patent: 4383993 (1983-05-01), Hussain et al.
patent: 4396615 (1983-08-01), Petrow et al.
patent: 4596795 (1986-06-01), Pitha
patent: 4742046 (1988-05-01), Bliah
patent: 4963367 (1990-10-01), Ecanow
patent: 5115805 (1992-05-01), Bommannan et al.
patent: 5120546 (1992-06-01), Hansen et al.
patent: 5152923 (1992-10-01), Weder et al.
patent: 5364632 (1994-11-01), Benita et al.
Duchateau, G., Dissertation, University of Leiden 1980.
Hussein, A., et al. "Nasal Absorption of Propanol from different dosage forms . . . " J. Pharmaceutical Sciences 69 (1980) 1411.
Kublik, H. "Optimierung von Arzneistoffzubereitungen Zur Nasalen Applikation 1993" Dissertation, Kiel.
Heckenmuller Harald
Kutz Gerd
Astra Aktiebolag
Griffin Ronald W.
LandOfFree
Pharmaceutical composition containing lipophilic drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing lipophilic drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing lipophilic drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227356